Overweight/obesity in adolescents with phenylketonuria: protective and predisposing factors
- PMID: 34144002
- PMCID: PMC9432224
- DOI: 10.1016/j.jped.2021.04.009
Overweight/obesity in adolescents with phenylketonuria: protective and predisposing factors
Abstract
Objective: To estimate the prevalence and factors associated with overweight/obesity development in adolescents with early diagnosed phenylketonuria treated exclusively by diet.
Methodology: In this cross-sectional study anthropometric measurements, serum phenylalanine levels, and 10 metabolites associated with lipid and carbohydrate metabolism were analyzed in 101 adolescents aged 10-20 years. Adolescents were categorized into overweight/obesity and eutrophic/low body mass index groups. These patients were compared using Student's t-test, Pearson's chi-square test, Wald's chi-square test for multivariate analysis. Further, to verify whether the prevalence of overweight/obesity found in the study population was similar to that in the general population, the authors compared the nutritional status of 46 patients aged 13-17 years with that of healthy students of the same age from the National School Health Survey using the chi-square test for adherence. The significance threshold was p < 0.5.
Results: The prevalence of overweight/obesity in adolescents was 27.7%. There was no difference in prevalence between sexes. Older age was a protective factor and Increased Homeostasis Model Assessment Insulin Resistance index and high phenylalanine and low-density lipoprotein cholesterol levels were predictive factors for overweight/obesity. The equality hypothesis was not rejected in the comparison of nutritional states of 46 patients aged 13-17 years and healthy students of the same age.
Conclusion: The prevalence of overweight/obesity in phenylketonuria adolescents was similar to what is found in healthy adolescents.
Keywords: Adolescent; Body mass index; Diet therapy; Obesity; Phenylketonuria.
Copyright © 2021 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
Conflict of interest statement
Conflicts of interest The authors declare no conflicts of interest.
Figures
References
-
- Rocha JC, van Rijn M, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, et al. Weight management in phenylketonuria: what should be monitored? Ann Nutr Metab. 2016;68:60–65. - PubMed
-
- Verduci E, Banderali G, Moretti F, Lassandro C, Cefalo G, Radaelli G, et al. Diet in children with phenylketonuria and risk of cardiovascular disease: a narrative overview. Nutr Metab Cardiovasc Dis. 2016;26:171–177. - PubMed
-
- Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, et al. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc. 2003;103:1167–1173. - PubMed
-
- White JE, Kronmal RA, Acosta PB. Excess weight among children with phenylketonuria. J Am Coll Nutr. 1982;1:293–303. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
